<DOC>
	<DOCNO>NCT02319265</DOCNO>
	<brief_summary>DAMSEL 2 pilot Phase II study patient sepsis . Stage 1 ass pharmacokinetics melatonin major metabolite single dose 50 100mg exogenous melatonin two small group patient sepsis order make dose dose interval decision Stage 2 . Stage 2 double blind randomise control trial melatonin patient sepsis dose dose interval decide Stage 1 . Measurements melatonin major metabolite , array biomarkers inflammation oxidative stress make , plus transcriptome ( mRNA ) analysis . This study inform plan large phase II trial .</brief_summary>
	<brief_title>Dose Assessment Melatonin Sepsis Trial</brief_title>
	<detailed_description>Antioxidant therapy target mitochondria potential reduce inflammation , mitochondrial damage organ dysfunction sepsis . Melatonin accumulate mitochondrion metabolite potent antioxidant anti-inflammatory activity , prevent organ dysfunction rat model sepsis . In recent Phase I dose escalation study ( DAMSEL 1 ) investigator show oral dos melatonin healthy subject well tolerated adverse event result level circulate melatonin major metabolite beneficial anti-inflammatory antioxidant action ex vivo studiesStage 1 ass pharmacokinetics melatonin major metabolite single dose 50 100mg exogenous melatonin two small group patient sepsis order make dose dose interval decision Stage 2 . Stage 2 double blind randomise control trial melatonin patient sepsis dose dose interval decide Stage 1 . Measurements melatonin major metabolite , array biomarkers inflammation oxidative stress make , plus transcriptome ( mRNA ) analysis . This study inform plan large phase II trial .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Adult patient ( 16 year ) ICU Aberdeen Royal Infirmary sepsis due community acquire pneumonia within 24h fulfil criterion sepsis clinical suspicion pneumonia presence chest Xray change consistent pneumonia recruit . The criteria sepsis : clinical suspicion evidence acute infection systemic inflammatory response syndrome , define two follow : 1 . Core temperature &lt; 36 &gt; 38Â°C ; 2. tachycardia : heart rate &gt; 90 beats/min ; 3. tachypnoea : respiratory rate &gt; 20 breaths/min ventilate ; 4. leucocyte count &gt; 12 x 109/L &lt; 4 x 109/L . &lt; 16 year old , life expectancy &lt; 24h , metastatic cancer immunosuppression , receive steroid ( &gt; 20mg/d prednisolone equivalent , use regularly &gt; 2 week prior ICU admission ) woman child bear potential without negative pregnancy test history surgical sterilization . patient receive fluvoxamine nifedipine , overt hepatic failure unable tolerate oral medication know hypersensitive trial medication and/or excipients</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>sepsis</keyword>
	<keyword>antioxidant</keyword>
	<keyword>melatonin</keyword>
	<keyword>inflammation</keyword>
</DOC>